Back to first-pass browser

First-pass extracted concept

engineered AAV capsids

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Engineered AAV capsids alter the delivery behavior of the vector. In the abstract, they are associated with CNS transduction, cell type specificity, and retrograde transport.

Source 1DOIPubMed

Resources required

They function as part of an AAV vector and therefore require compatible viral packaging and a chosen cargo genome.

Source 1DOIPubMed

What problem it solves

They address the problem of getting gene delivery to the right brain regions or cell populations.

Source 1DOIPubMed

What it does not solve

The abstract does not support that capsid engineering alone is sufficient to control transgene expression after delivery.

Source 1DOIPubMed

Alternatives

The review contrasts capsid engineering with cargo/regulatory engineering as the other main design axis.

Source 1DOIPubMed

Evidence Snippets

Several engineered AAV capsids with unique tropisms have been identified, including variants with enhanced central nervous system transduction, cell type specificity, and retrograde transport in neurons.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1capability summarysupports2022Source 1DOIPubMed

Engineered AAV capsids with unique tropisms include variants associated with enhanced central nervous system transduction, cell type specificity, and retrograde transport in neurons.

Claim 2engineering axissupports2022Source 1DOIPubMed

AAV vectors have two engineerable features, the capsid and the cargo, which can be modified to alter tropism and transgene expression control.

Claim 3review scopesupports2022Source 1DOIPubMed

The review presents a comprehensive capsid-and-cargo AAV toolkit for genetic access to molecularly defined brain cell types.